Artivion [AORT] vs AdaptHealth [AHCO] Detailed Stock Comparison

Artivion Inc.

NYSE
Loading...

AdaptHealth Corp.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Artivion Inc. wins in 8 metrics, AdaptHealth Corp. wins in 12 metrics, with 0 ties. AdaptHealth Corp. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Artivion Inc. AdaptHealth Corp. Better
P/E Ratio (TTM) 179.71 16.64 AdaptHealth Corp.
Price-to-Book Ratio 4.03 1.11 AdaptHealth Corp.
Debt-to-Equity Ratio 57.67 124.67 Artivion Inc.
PEG Ratio -1.59 -0.05 AdaptHealth Corp.
EV/EBITDA 36.67 6.03 AdaptHealth Corp.
Profit Margin (TTM) 2.21% -2.18% Artivion Inc.
Operating Margin (TTM) 8.09% 6.20% Artivion Inc.
EBITDA Margin (TTM) 8.09% 6.20% Artivion Inc.
Return on Equity 2.70% -4.25% Artivion Inc.
Return on Assets (TTM) 2.34% 2.91% AdaptHealth Corp.
Free Cash Flow (TTM) $839,000 $219.38M AdaptHealth Corp.
1-Year Return -28.85% 18.14% AdaptHealth Corp.
Price-to-Sales Ratio (TTM) 4.15 0.53 AdaptHealth Corp.
Enterprise Value $1.97B $3.53B AdaptHealth Corp.
EV/Revenue Ratio 4.47 1.09 AdaptHealth Corp.
Gross Profit Margin (TTM) 63.06% 54.14% Artivion Inc.
Revenue per Share (TTM) $10 $24 AdaptHealth Corp.
Earnings per Share (Diluted) $0.21 $-0.52 Artivion Inc.
Beta (Stock Volatility) 1.62 1.50 AdaptHealth Corp.
Short % of Float 4.13% 7.98% Artivion Inc.

Artivion Inc. vs AdaptHealth Corp. Stock Performance Analysis

Loading Price Chart...

AORT
AHCO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Artivion Inc.4.83%3.33%-7.47%-43.66%-53.56%-52.61%
AdaptHealth Corp.0.55%7.24%7.35%-13.43%5.38%13.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Artivion Inc.-28.85%25.55%-29.37%70.34%288.03%318.75%
AdaptHealth Corp.18.14%0.59%-63.29%4.74%4.74%4.74%

Performance & Financial Health Analysis: Artivion Inc. vs AdaptHealth Corp.

MetricAORTAHCO
Market Information
Market Cap i$1.83B$1.73B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i273,5521,287,211
90 Day Avg. Volume i406,5541,413,667
Last Close$21.07$10.96
52 Week Range$19.16 - $48.25$8.51 - $13.43
% from 52W High-56.33%-18.39%
All-Time High$48.25 (Dec 17, 2025)$41.58 (Feb 01, 2021)
% from All-Time High-56.33%-73.64%
Growth Metrics
Quarterly Revenue Growth0.19%-0.01%
Quarterly Earnings Growth0.19%0.00%
Financial Health
Profit Margin (TTM) i0.02%-0.02%
Operating Margin (TTM) i0.08%0.06%
Return on Equity (TTM) i0.03%-0.04%
Debt to Equity (MRQ) i57.67124.67
Cash & Liquidity
Book Value per Share (MRQ)$9.37$11.46
Cash per Share (MRQ)$1.36$0.78
Operating Cash Flow (TTM) i$39.88M$601.77M
Levered Free Cash Flow (TTM) i$-20,097,624$246.52M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Artivion Inc. vs AdaptHealth Corp.

MetricAORT (Apr 26, 2026)AHCO (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i179.7116.64
Forward P/E i32.6510.14
PEG Ratio i-1.59-0.05
Price to Sales (TTM) i4.150.53
Price to Book (MRQ) i4.031.11
Market Capitalization
Market Capitalization i$1.83B$1.73B
Enterprise Value i$1.97B$3.53B
Enterprise Value Metrics
Enterprise to Revenue i4.471.09
Enterprise to EBITDA i36.676.03
Risk & Other Metrics
Beta i1.621.50
Book Value per Share (MRQ) i$9.37$11.46

Financial Statements Comparison: Artivion Inc. vs AdaptHealth Corp.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAORT (2025)AHCO (2025)
Revenue/Sales i441.33M3.24B
Cost of Goods Sold i157.10M2.64B
COGS % of Revenue i35.6%81.2%
Gross Profit i284.23M609.20M
Gross Margin i64.4%18.8%
Research & Development i30.99MN/A
Operating Income (EBIT) i26.75M186.27M
Operating Margin i6.1%5.7%
EBITDA i59.48M567.92M
EBITDA Margin i13.5%17.5%
Pre-Tax Income i14.78M-15.15M
Pre-Tax Income % of Revenue i3.3%-0.5%
Income Tax i5.01M50.88M
Income Tax % of Revenue i1.1%1.6%
Net Income (Profit) i9.77M-66.04M
Profit Margin i2.2%-2.0%

Balance Sheet & Liquidity Metrics

MetricAORT (2025)AHCO (2025)
Cash & Equivalents i64.91M106.14M
Total Current Assets i358.08M728.90M
Total Current Assets % of Revenue i81.1%22.5%
Total Current Liabilities i101.56M712.39M
Total Current Liabilities % of Revenue i23.0%22.0%
Long-Term Debt i252.24M1.83B
Long-Term Debt % of Revenue i57.2%56.5%
Total Shareholders Equity i448.23M1.53B
Retained Earnings i-51.50M-632.97M
Retained Earnings % of Revenue i-11.7%-19.5%
Property, Plant & Equipment i34.70M1.11B

Cash Flow Statement Comparison

MetricAORT (2025)AHCO (2025)
Operating Cash Flow i41.11M567.45M
Operating Cash Flow % of Revenue i9.3%17.5%
Capital Expenditures iN/A-382.39M
Free Cash Flow i839,000219.38M
FCF Margin i0.2%6.8%
Debt Repayment i-2.46M-268.48M
Common Stock Repurchase i00

Short Interest & Institutional Ownership Analysis

MetricAORTAHCO
Shares Short i1.67M8.32M
Short Ratio i4.284.89
Short % of Float i4.13%7.98%
Shares Outstanding i47.84M132.52M
Float Shares i45.40M88.38M
% Held by Insiders i4.52%2.94%
% Held by Institutions i91.48%108.99%
% Held by Public i4.00%-11.93%

Dividend Analysis & Yield Comparison: Artivion Inc. vs AdaptHealth Corp.

MetricAORTAHCO
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00N/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00N/A
Ex-Dividend DateN/AN/A